Latest Deals

Zimmer Biomet plans to finance the transaction using cash and debt financing. Credit: T Schneider / Shutterstock

Zimmer Biomet has signed a definitive agreement to acquire Paragon 28 for an enterprise value of approximately $1.2bn, which will significantly bolster the former’s foot and ankle offerings. The cash transaction is valued at $1.1bn in equity value, with Paragon 28 shareholders receiving $13.00 per share upfront. Additionally, the agreement includes a contingent value right (CVR) that could add up to $1.00 per share based on future revenue milestones.   

Neko Health has completed a $260m Series B funding round to further R&D and US and European market expansion efforts for its healthcare scanner. Co-founded by Hjalmar Nilsonne and Daniel Ek the health tech startup’s non-invasive Neko Health Scan diagnostic uses 70 scanners and a combination of technologies, including thermal imaging and 2D/3D photography, to map approximately 50 million health data points in a user’s body. 

US software company Rad AI has secured $60m in a Series C financing round as the uptake of AI in radiological workflows shows no signs of slowing. The round, which was oversubscribed, was led by US digital health investors Transformation Capital, with participation from existing investors such as Khosla Ventures, World Innovation Lab, and UP2398. 

Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its anticipated target. The US-based company sold 12 million shares of its common stock for $17 each. The artificial pancreas maker had initially targeted a raise of $114.4m via an anticipated share price range between $14m and $16m.